Capital Research Global Investors
EXAS

Capital Research Global Investors’s Exact Sciences EXAS Stock Holding History

Capital Research Global Investors’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-592,020
Closed -$7.91M – 432
2016
Q4 		$7.91M Hold
592,020
– – ﹤0.01% 414
2016
Q3 		$11M Sell
592,020
-455,980
-44% -$8.04M ﹤0.01% 394
2016
Q2 		$12.8M Sell
1,048,000
-1,440,762
-58% -$10.9M ﹤0.01% 385
2016
Q1 		$16.8M Sell
2,488,762
-3,043,082
-55% -$19.5M 0.01% 384
2015
Q4 		$51.1M Sell
5,531,844
-4,659,509
-46% -$43.3M 0.02% 327
2015
Q3 		$183M Buy
10,191,353
+746,300
+8% +$17.1M 0.07% 234
2015
Q2 		$281M Buy
9,445,053
+110,700
+1% +$2.78M 0.09% 212
2015
Q1 		$206M Buy
9,334,353
+3,064,102
+49% +$77.7M 0.07% 236
2014
Q4 		$172M Buy
6,270,251
+1,441,037
+30% +$35.1M 0.06% 251
2014
Q3 		$93.6M Buy
4,829,214
+1,452,392
+43% +$26.6M 0.03% 303
2014
Q2 		$57.5M Buy
+3,376,822
New +$46.5M 0.02% 337

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Capital Research Global Investors's EXAS Position: Q1 2017 in Review

Capital Research Global Investors sold out of Exact Sciences (EXAS) in Q1 2017, closing a stake of 592,020 shares — an estimated $7.91M sold.

Capital Research Global Investors first reported a position in EXAS in Q2 2014 and held it in 11 quarters. The position peaked at $281M in Q2 2015. 225 funds tracked by Wall St. Rank hold EXAS as of Q1 2017.

  • Capital Research Global Investors reported no remaining Exact Sciences position as of Q1 2017 after selling out during the quarter.
  • Capital Research Global Investors sold 592,020 Exact Sciences shares in Q1 2017, an estimated $7.91M.
  • Capital Research Global Investors first reported a position in Exact Sciences in Q2 2014 and held it in 11 quarters.
  • Capital Research Global Investors's Exact Sciences position peaked at $281M in Q2 2015.
  • 225 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2017.

Based on Capital Research Global Investors's 13F filing for Q1 2017, filed 15 May 2017.